Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. Preoperative ...

We've all heard about the amazing benefits of GLP-1 medications in managing weight and blood sugar, but what happens when ...

Highlights of the findings include: Stopping Ozempic three to five days prior to surgery was identified as an independent risk factor for delayed emergence from anesthesia. In contrast ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

This cohort study found no significant association between the preoperative use of glucagon-like peptide-1 receptor agonists (GLP-1 ...

GLP-1 receptor agonists were associated with better graft and patient survival. Clinical trials are needed to confirm these ...

Patients taking GLP-1 drugs also had a 31% lower risk of dying ... She is an associate professor of surgery and population health at NYU Grossman School of Medicine. Orandi said this risk can ...